Publicacións en colaboración con investigadores/as de University of Paris-Sorbonne (3)

2022

  1. Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)

    Genetics in Medicine, Vol. 24, Núm. 10, pp. 2004-2013

2020

  1. Molecular rescue of DYRK1A overexpression alterations in mice with fontup® dietary supplement: Role of green tea catechins

    International Journal of Molecular Sciences, Vol. 21, Núm. 4

2016

  1. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial

    The Lancet Neurology, Vol. 15, Núm. 8, pp. 801-810